Journal article
Long-Term Clinical Outcome After Postchemotherapy Retroperitoneal Lymph Node Dissection in Men With Residual Teratoma
Abstract
PURPOSE: The histologic finding of teratoma occurs in approximately 40% of all postchemotherapy retroperitoneal lymph node dissections (PC-RPLND). We evaluated patients at our institution undergoing initial PC-RPLND for teratoma to determine their clinical outcome.
PATIENTS AND METHODS: We identified 210 patients from 1989 to 2003 with nonseminomatous germ cell tumors (NSGCT) who underwent initial PC-RPLND and were found to have only teratoma …
Authors
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
Journal
Journal of Clinical Oncology, Vol. 25, No. 9, pp. 1033–1037
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 20, 2007
DOI
10.1200/jco.2005.05.4791
ISSN
0732-183X
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Antineoplastic AgentsCombined Modality TherapyDisease-Free SurvivalFollow-Up StudiesHumansKaplan-Meier EstimateLymph Node ExcisionLymph NodesMaleNeoplasm StagingNeoplasm, ResidualNew York CityPredictive Value of TestsPrognosisProportional Hazards ModelsRegistriesRetroperitoneal NeoplasmsRetroperitoneal SpaceRisk AssessmentTeratomaTesticular NeoplasmsTime FactorsTreatment Outcome